Join us for two-piano performances by Brenda Casey and Pat Todd in the first and second of a series of 2015 Concerts to Conquer Kidney Cancer. The concerts are fundraisers to benefit ACKC and kidney cancer research. View the program. Meet the performers. Saturday, May 16 and Sunday, May 17, 3 pm, 18 Fair Street, Guilford, CT. Donation: $40 per person, $100 per sponsor. Reservations: 203 458 1310.
On March 4, 2015, the FDA approved the Bristo-Myers Squibb (BMS) immunotherapy drug nivolumab (Opdivo) for use in non-small cell lung cancer (NSCLC) patients for whom other drugs have failed. The approval was based on interim results in a Phase III trial testing nivolumab, at 3 mg/kg, against docetaxel, a chemotherapy drug. Nivolumb was found to have extended overall survival (OS) by three months over docetaxel, giving patients on nivolumab a median OS of 9.2… More →
A recent segment on NPR, segment, reported about a study, involving tens of thousands of participants over a 50-year period, by Dr. Barbara Cohn from UC Berkeley looking into the effect of environmental factors on the development of breast cancer in mothers and their children. Dr. Cohn plans to map out what’s called the “exposome” (see exposome), which is a map of the exposure of an individual over his or her lifetime to various environmental and… More →
John Ebos of Roswell Park Cancer Institute was granted a Career Development Award by the Congressionally Directed Medical Research Programs of the Department of Defense (DoD) to study, using a pre-clinical model, rebound and resistance to targeted therapies in RCC. This two-year grant was funded at $602,996 in Fiscal Year 2013 (the latest award year). This project is designed to answer a number of important questions, in regard to targeted therapy, that have not been… More →
Today ACKC is launching its new website, updating older material and adding new content, which we will continue to do in the future. Two new features on the Homepage are “News” and “Point of View” essays. News will commence with two articles, one highlighting two studies on the use of sunitinib (Sutent) in the elderly, and a second article featuring Maria Czyzyk-Krzeska from the University of Cincinnati. Maria is one of the two winners of… More →